
Production Operator
Oncoinvent AS
- Frist 8.6.2023
- Ansettelsesform Fast
Oncoinvent AS - spennende stilling som produksjonsoperatør
Production Operator
Oncoinvent AS is looking for a production operator to strengthen the production team at the company’s manufacturing facility in Oslo. The production team at Oncoinvent is tasked with the development and GMP compliant production of radiopharmaceuticals. The position is an exciting opportunity to work in an innovative and dynamic start-up company and participate in the development of novel pharmaceuticals.
The successful candidate will, together with the production team and other Oncoinvent staff, drive the manufacture and development of Radspherin® for pre-clinical and early-phase clinical trials.
This position requires work with radioactive materials. A successful candidate is therefore expected to comply with radiation protection and other health and safety procedures during laboratory- and production scale experiments, and GMP production activities.
Key responsibilities:
- GMP compliant routine production of radium-224, calcium carbonate microparticles and Radspherin® to supply clinical trials.
- Routine cleaning and environmental monitoring of GMP production rooms, associated technical rooms and general laboratory.
- Handling of incoming goods, raw materials stock keeping and housekeeping including handling of radioactive and non-active waste.
- Help with maintaining the calibration and qualification status of Oncoinvent’s production facility, equipment and instruments.
- When necessary, assist in the planning, designing and conducting laboratory- and production scale experiments with the aim of increasing the yield and scale of the Ra-224 drug substance and Radspherin® process.
- When necessary, support the writing and review of GMP compliant batch manufacturing records and operating procedures.
- Develop and maintain a good working knowledge in Good Manufacturing Practice (GMP) and participate in annual GMP training.
- Support production, QC and QA in the investigation and closure of any deviations. Aid production, QC and QA in the implementation of Corrective and Preventative Actions (CAPA).
Qualifications and experience:
The holder of this position should have the following documented qualifications and experience:
- High school degree in science- or a technical relevant discipline.
- Working knowledge in Norwegian and English.
- 1-3 years practical, hands-on experience in the production of pharmaceuticals.
The following experience is desirable:
- Familiarity with GMP regulations and experience with working in clean rooms is an advantage.
- A successful candidate will have to be able to work in a multidisciplinary team while being able to plan and perform practical work independently.
- The production of pharmaceuticals is highly regulated, and a successful candidate will be expected to show attention to detail with respect to planning and documentation of practical work.
Location
The holder of this position will be based at Oncoinvent AS, Gullhaugveien 7, 0484 Oslo. The position will report to the Head of Production.
Application deadline: We are reviewing the applications on a rolling basis.
Please submit your application with a motivational letter stating “why Oncoinvent” and what you can contribute to the position as well as an updated CV. Application without this will not be reviewed further.
JobbMatch
BetaEr du kvalifisert for jobben?
Nysgjerrig på om du kvalifiserer til denne jobben? Med JobbMatch får du umiddelbar tilbakemelding på hvor godt din profil matcher stillingsutlysningen.
Om arbeidsgiveren
The Oncoinvent team consists of 50 employees and the company anticipates further growth.
Oncoinvent holds a state-of-the-art manufacturing facility to produce drug products intended for use in pre-clinical and clinical trials. Clinical trials for Oncoinvent’s lead product, Radspherin® are ongoing. For further details on Oncoinvent see www.oncoinvent.com.
The facility holds a GMP certificate from the Norwegian Medical Agency. The approval provides the company with the necessary flexibility and capacity for manufacturing clinical trial material for both patients and trial sites, as well as developing the company further.
The company’s lead product candidate Radspherin® is a novel alpha-emitting radioactive microsphere suspension designed for treatment of micro-metastatic cancers in body cavities. The radium-224 based therapeutic, Radspherin® has shown strong and consistent anticancer activity at doses being essentially non-toxic in preclinical studies. It is anticipated that the product can potentially treat several forms of micro-metastatic cancer.
The development programs of the pipeline of the company include targeted radionuclide therapy for treatment of various solid cancers. The main focus of discovery is on alpha-emitting radionuclides for treatment by regional administration of the drug in body compartments with disseminated solid tumours.
- Sektor: Privat
- Sted: Gullhaugveien 7, 0484 Oslo
- Bransje: Farmasi og legemiddel, Industri og produksjon, Kjemisk industri
- Stillingsfunksjon: Produksjon, Produksjonsteknikk/Prosessteknikk
Nøkkelord
Produksjon, Legemidler, GMP, Kreft, Operatør
Annonseinformasjon
- FINN-kode 302336574
- Sist endret
